Products for Research Use Only
RegisterLogin

Cefpodoxime Proxetil

CAT: 0804-HY-N7101-01Size: 10 mM - 1 mLDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N7101-01Size:10 mM - 1 mL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cefpodoxime Proxetil is an orally active broad spectrum third-generation cephalosporin with potent antibacterial activity against both Gram-positive and Gram-negative bacteria including staphylococci, streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pnuemoniae, Citrobacter spp, and Proteus spp. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis. Cefpodoxime Proxetil can be used against skin structure infections, acute otitis media, pharyngitis, tonsillitis, upper respiratory tract infection, urinary tract infections and sexually transmitted diseases[1][2][3][4][5].
CAS Number
87239-81-4
Product Name Alternative
U-76,252; CS-807
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Bacterial; Penicillin-binding protein (PBP)
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cefpodoxime-proxetil.html
Purity
98.93
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C(N12)=C(COC)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)OC(OC(OC(C)C)=O)C
Molecular Formula
C21H27N5O9S2
Molecular Weight
557.60
Precautions
H302, H315, H319, H335
References & Citations
[1]Todd W. M. (1994) . Cefpodoxime proxetil: a comprehensive review. International journal of antimicrobial agents, 4 (1), 37–62. |[2]Date, A. A., & Nagarsenker, M. S. (2007) . Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. International journal of pharmaceutics, 329 (1-2), 166–172.|[3]Borin M. T. (1991) . A review of the pharmacokinetics of cefpodoxime proxetil. Drugs, 42 Suppl 3, 13–21. |[4]Frampton, J. E., et al., (1992) . Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs, 44 (5), 889–917. |[5]Pahwa R, Rana A S, Dhimans S, et al. Cefpodoxime proxetil: an update on analytical, clinical and pharmacological aspects [J]. J Curr Chem Pharm Sc, 2015, 5 (2) : 56-66.|[6]Utsui, Y., et al., (1987) . In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrobial agents and chemotherapy, 31 (7), 1085–1092.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam

Related Products

CatalogName
HY-A0251-01Cefpodoxime
HY-A0251SCefpodoxime-d3
HY-A0251RCefpodoxime (Standard)

Alternative Products

CatalogName
B4973-5Cefpodoxime Proxetil
416494-01∆2-Cefpodoxime Proxetil
TRC-C243875-10MGCefpodoxime Proxetil Isopropylcarbamate
A17600-1000Cefpodoxime proxetil 1g

Popular Products